From the Food and Drug Administration.
Henney
J E
JE
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D019446:Endotoxemia / Q000139:chemically induced; D005839:Gentamicins / Q000009:adverse effects*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007595:Joint Prosthesis; D000077205:Pioglitazone; D000077154:Rosiglitazone; D013704:Temporomandibular Joint; D013705:Temporomandibular Joint Disorders / Q000601:surgery*; D013844:Thiazoles / Q000627:therapeutic use*; D045162:Thiazolidinediones; D014481:United States; D014486:United States Food and Drug Administration
D005839:Gentamicins; D007004:Hypoglycemic Agents; D013844:Thiazoles; D045162:Thiazolidinediones; D000077154:Rosiglitazone; D000077205:Pioglitazone